Pharmacological treatment of primary negative symptoms in schizophrenia: A systematic review

This publication has 194 references indexed in Scilit:

• Pergolide as Adjuvant Therapy to Amisulpride in the Treatment of Negative and Depressive Symptoms in Schizophrenia
  Pharmacopsychiatry, 2006
• The NIMH-MATRICS Consensus Statement on Negative Symptoms
  Schizophrenia Bulletin, 2006
• Estrogen for schizophrenia
  Cochrane Database of Systematic Reviews, 2005
• Food and Drug Administration Perspective on Negative Symptoms in Schizophrenia as a Target for a Drug Treatment Claim
  Schizophrenia Bulletin, 2005
• Negative symptoms of schizophrenia are improved by the addition of paroxetine to neuroleptics: a double-blind placebo-controlled study
  International Clinical Psychopharmacology, 2005
• Patients with schizophrenia previously stabilized on conventional depot antipsychotics experience significant clinical improvements following treatment with long-acting risperidone
  European Psychiatry, 2004
• BATTLING BOREDOM: GROUP COGNITIVE BEHAVIOUR THERAPY FOR NEGATIVE SYMPTOMS OF SCHIZOPHRENIA
  Behavioural and Cognitive Psychotherapy, 2002
• Amisulpride has a superior benefit/risk profile to haloperidol in schizophrenia: results of a multicentre, double-blind study (the Amisulpride Study Group^*
  European Psychiatry, 2000
• Therapeutic effect and safety of increasing doses of risperidone (R 64766) in psychotic patients
  Psychopharmacology, 1989
• Zotepine in the Treatment of Negative Symptoms in Chronic Schizophrenia
  Pharmacopsychiatry, 1987